Respimat inhaler

DEVICE2 trials

Sponsors

Boehringer Ingelheim, GlaxoSmithKline

Conditions

AsthmaPulmonary Disease, Chronic Obstructive

Phase 3

A Study to Determine the Effect of Tiotropium + Olodaterol Fixed Dose Combination on Exercise Endurance Time During Constant Work Rate Cycle Ergometry Test in COPD

CompletedNCT01525615

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2012-02-29End: 2013-09-30Updated: 2016-08-29

Effectiveness of Fluticasone Furoate/ Umeclidinium/ Vilanterol (FF/UMEC/VI) Using the Connected Inhaler System (CIS) as Compared With Fluticasone Proprionate/ Salmeterol (FP/SAL) Plus Tiotropium (TIO) in Inadequately Controlled Asthma

WithdrawnNCT03376932

GlaxoSmithKlineAsthma

Start: 2019-01-18End: 2021-02-03Updated: 2019-03-25

Related Papers

Comparative measurement properties of constant work rate cycling and the endurance shuttle walking test in COPD: the TORRACTO<sup>®</sup> clinical trial

Therapeutic Advances in Respiratory Disease2020-01-015 citations

Comparative Measurement Properties of Constant Work-Rate Cycling and Endurance Shuttle Walking in Patients with COPD: Data from the TORRACTO Study

Pneumologie2018-02-21

Effect of 12 weeks of once-daily tiotropium/olodaterol on exercise endurance during constant work-rate cycling and endurance shuttle walking in chronic obstructive pulmonary disease

Therapeutic Advances in Respiratory Disease2018-01-0134 citations

Evaluation of the effects of olodaterol on exercise endurance in patients with chronic obstructive pulmonary disease: results from two 6-week crossover studies.

2016-07-0614 citations

P250 Effects Of 12 Weeks Of Once-daily Tiotropium And Olodaterol Fixed-dose Combination On Exercise Endurance In Patients With Copd

Thorax2014-11-1014 citations